A comprehensive guide to movement disorders

Parkinson’s disease is a progressive neurological condition that primarily affects movement. Slowness, muscle stiffness, resting tremor, reduced arm swing and changes in balance or gait may occur.

Non-motor symptoms are also important. Sleep disturbance, constipation, reduced sense of smell, fatigue, mood changes, cognitive symptoms and blood-pressure fluctuations may be part of the clinical picture.

Diagnosis is not based on a single blood test or scan. Medical history, neurological examination, the course of symptoms and, when appropriate, tests used to exclude other causes are interpreted together.

Treatment is individualised according to symptoms, age, other medical conditions and daily-life needs. Medication timing or dosage should not be changed without medical advice.

Tremor is rhythmic involuntary shaking that may appear at rest, while maintaining a posture or during movement. Not every tremor is caused by Parkinson’s disease.

The body part involved, the task that makes shaking worse and its relationship with caffeine, stress, sleep or medication provide useful diagnostic information.

Essential tremor, enhanced physiological tremor, thyroid disorders, medication effects and several neurological conditions may produce similar complaints.

If tremor affects eating, writing, work or social life, describing specific examples helps define realistic treatment goals.

Dystonia may cause repetitive movements and abnormal postures through sustained or intermittent muscle contractions. It can involve the neck, eyelids, jaw, voice, hand or foot.

Examination considers the direction and duration of contractions, pain, task-specific spread and whether a sensory trick such as light touch provides temporary relief.

Depending on the type and distribution, management may include medication, botulinum toxin, rehabilitation or advanced treatment assessment in selected cases.

Severe new contractions accompanied by difficulty swallowing, breathing problems or altered consciousness require urgent assessment.

Ataxia is a clinical sign describing impaired balance and coordination rather than one single disease. It may affect walking, speech, eye movements and control of the arms or legs.

The timing of onset, falls, double vision, numbness, family history and medication or alcohol use can guide the evaluation.

Blood tests, imaging, vestibular testing or genetic counselling may be considered according to clinical need; the same tests are not required for every patient.

Sudden imbalance with speech difficulty, weakness, double vision or a severe headache may indicate stroke. Emergency services should be contacted immediately.

Multiple system atrophy and progressive supranuclear palsy are atypical parkinsonian disorders that may share features with Parkinson’s disease. Early falls, autonomic problems, eye-movement changes and swallowing or speech difficulties are important clues.

Blood-pressure and urinary symptoms can be prominent in MSA, while backward falls and impaired vertical eye movements may occur in PSP. No single symptom is sufficient for diagnosis.

Diagnosis often requires observation over time and combined interpretation of neurological examination, imaging and symptom-directed investigations.

Fall prevention, swallowing safety, nutrition, communication and support for everyday activities are important parts of follow-up.

Botulinum toxin aims to temporarily reduce excessive activity in selected muscles in focal dystonias and certain related movement disorders.

Target muscles and dosage are determined by detailed examination and previous response, rather than by the diagnostic label alone.

Onset and duration of benefit vary. Expected benefit, limitations and risks such as temporary pain or weakness should be discussed before treatment.

Marked swallowing or breathing difficulty, or widespread weakness after an injection, requires urgent medical assistance.

Deep brain stimulation is a surgical treatment designed to regulate selected movement symptoms in carefully chosen patients. It does not cure the underlying disease and does not affect every symptom equally.

Assessment considers diagnosis, response to medication, motor fluctuations, cognition, psychiatric history, imaging and surgical risks.

Device programming, medication adjustments and regular follow-up are required after surgery. Goals should be defined realistically with the patient and family.

DBS may not reliably improve balance, speech, freezing, cognition or non-motor symptoms. The symptoms most likely to benefit should be explained before surgery.